Is Hemostemix Inc (HMTXF) a Buy, Sell, or Hold?
OTC : HMTXF
Hemostemix Inc
$0.03824 USD
$0 (0.0%)
- Volume
- 6K
- Average Volume
- 4.16K
- Market Capitalization
- $7.56M
- P/E Ratio
- -2.74
- Dividend Yield
- 0.00%
- Price Target
- Year High
- $0.10
- Year Low
- $0.04
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $0.24
Company Overview
OTC
Thomas A. Smeenk
Biotechnology
Healthcare
HMTXF
488
CA
USD
Liquidity Metrics
-0.66
0.24
0.24
0.10
0.00
Sales & Valuation
-$
0.00
-1.94
-2.26
-0.03
Profitability
-$0.0288
-$4.71M
0.00%
0.00%
80.07%
-991.47%
P/E Metrics
-2.74
-0.03
-0.03
Analyst Price Target & Rating
0/5
0 Analysts
%
Poll Results
About Hemostemix Inc (OTC:HMTXF) Stock
Hemostemix, Inc. is a clinical-stage biotechnology company, which is focused on developing and commercializing a proprietary autologous cell therapy to treat ischemic diseases. The firm's, ACP-01, lead clinical stage candidate, is an autologous cell therapy for the treatment of critical limb ischemia. The company was founded by Roger Bergersen and Thomas A. Smeenk in 2006 and is headquartered in Calgary, Canada. ...
2026-07-08 10:08:00
Calgary, Alberta--(Newsfile Corp. - July 8, 2026) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) ("Hemostemix" or the "Company"), the leading autologous (patient's own stem cells) regenerative medicine company is pleased to announce that it has filed its application under the Bahamas Longevity and Regenerative Therapies Act (LARTA) for a commercial Phase I Basket Clinical Trial evaluating VesCell™ in patients suffering from vascular dementia, refractory angina and pain. Published in Circulation, Tresukosol et al evaluated VesCell™ in a phase I clinical trial of 24 patients suffering from chronic stable angina.
Hemostemix Closes $360,000 First Tranche of Private Placement
2026-06-26 08:47:00
Calgary, Alberta--(Newsfile Corp. - June 26, 2026) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) ("Hemostemix" or the "Company") is pleased to announce it has closed the first tranche of its previously announced non-brokered private placement of units (the "Offering"), as originally disclosed on June 17, 2026. The Company raised aggregate gross proceeds of CDN$360,000 under the first tranche through the issuance of 7,200,000 units ("Units") at a price of CDN$0.05 per Unit.
Hemostemix' $1,000,000 Private Placement and Update
2026-06-17 17:22:00
Calgary, Alberta--(Newsfile Corp. - June 17, 2026) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) is pleased to announce that the Company is closing up to $1,000,000 of financing in tranches from the sale of Units at $0.05 each. Each Unit shall consist of one Common Share in the capital of the Company ("Common Share") and one half common share purchase warrant ("1/2 Warrant"), with each whole Warrant (2 x 1/2 Warrants) entitling the holder to acquire one Common Share at a price of $0.12 per Common Share for a period of 24 months from the closing of the Offering, subject to the accelerated expiry provision described below.
Frequently Asked Questions
-
What is the current Hemostemix Inc (HMTXF) stock price?
-
Hemostemix Inc(OTC:HMTXF) stock price is $0.03824 in the last trading session. During the trading session, HMTXF stock reached the peak price of $0.1033 while $0.035 was the lowest point it dropped to. The percentage change in HMTXF stock occurred in the recent session was 0.0% while the dollar amount for the price change in HMTXF stock was $0.
-
HMTXF's industry and sector of operation?
-
The OTC listed HMTXF is part of Biotechnology industry that operates in the broader Healthcare sector.
-
Who are the executives of HMTXF?
-
Thomas A. Smeenk | Co-Founder, President, Chief Executive Officer & Director
Christina Wu | Interim Chief Financial Officer
Fraser C. Henderson | Chief Medical Officer
Peter Pavlin | Vice President of Operations
| -
How many employees does HMTXF have?
-
Number of HMTXF employees currently stands at 488. HMTXF operates from 707-7th Avenue SW, Calgary, AB T2P 3H6, CA.
-
Link for HMTXF official website?
-
Official Website of HMTXF is: http://www.hemostemix.com
-
How do I contact HMTXF?
-
HMTXF could be contacted at phone #+1 905 580 4170 and can also be accessed through its website. HMTXF operates from 707-7th Avenue SW, Calgary, AB T2P 3H6, CA.
-
How many shares of HMTXF are traded daily?
-
The average number of HMTXF shares traded daily for last 3 months was 4.16K.
-
What is the market cap of HMTXF currently?
-
The market value of HMTXF currently stands at $7.56M with its latest stock price at $0.03824